|
|
Magnetic resonance and ultrasound imaging as biomarkers for detection and monitoring of Parsonage-Turner Syndrome (PTS) |
| 1 R21 TR003033-01A1 |
SNEAG, DARRYL |
NCATS |
2020 |
|
|
Development and validation of clinical outcome assessments in LGMD2A |
| 1 R21 TR003184-01 |
JOHNSON, NICHOLAS ELWOOD |
NCATS |
2020 |
|
|
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis |
| 1 R01 AI143676-01A1 |
CHEN, YOUHAI H |
NIAID |
2020 |
|
|
Translational approaches to improve understanding and outcome in Tuberculous meningitis |
| 1 R01 AI145436-01A1 |
DARTOIS, VERONIQUE |
NIAID |
2020 |
|
|
Molecular Mechanisms of IL-17-dependent autoimmune signaling |
| 1 R01 AI147383-01A1 |
GAFFEN, SARAH L |
NIAID |
2020 |
|
|
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2 |
| 1 R01 AI148178-01 |
SCHWAB, SUSAN RUTH |
NIAID |
2020 |
|
|
Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunity |
| 1 R01 AI148711-01A1 |
LEAVENWORTH, JIANMEI WU |
NIAID |
2020 |
|
|
The pathogenic role of miR-92a in the regulation of T helper cell responses in EAE and MS |
| 1 R01 AI151953-01 |
GOPAL, MURUGAIYAN |
NIAID |
2020 |
|
|
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity |
| 1 R01 AI152251-01 |
ROSTAMI, AM |
NIAID |
2020 |
|
|
Role of miRNA Dysregulation on T Cell Differentiation and Function in MS |
| 1 R01 AI152435-01 |
LOVETT-RACKE, AMY E |
NIAID |
2020 |
